The effect of the novel inhibitor of receptor activated and calcium store-operated nonselective cation chan nels, (RS)-(3,4-dihydro-6, 7 -dimethoxyisoquinoline-l-,/I )-2phenyl-N,N-di-[2(2,3,4-trimethoxyphenyl) ethyllacetamide (LOE 908 MS), on focal cerebral ischemia was studied in halo thane-anesthetized rats submitted to permanent suture occlu sion of the right middle cerebral artery (MCA), The treated group (n = 7) received subcutaneous injections of 30 mg/kg LOE 908 MS (in
water declined to below 80% of controll steadily increased by -50% during the initial 6 h of vascular occlusion relative to the first set of data 10 min postocclusion, In the treated animals, in contrast, the ADC lesion volume declined by -20% during the same intervaL Treatment also led to a significant reduction in the number of periinfarct depolarizations, After 6 h of vascular occlusion, blood flow was significantly higher in the treated animals, and the volume of ATP-depleted and morphologically injured tissue representing the infarct core was 60-70% smaller. The volume of severely acidic tissue, in contrast, did not differ, indicating that LOE 908 MS does not reduce the size of ischemic penumbra, These findings demonstrate that post occlusion treatment of permanent focal ischemia with LOE 908 MS delays the expansion of the infarct core into the penumbra for a duration of at least 6 h and therefore substantially pro longs the window of opportunity for the reversal of the isch emic impact in the peripheral parts of the evolving infarct. Key Words: Diffusion-weighted magnetic resonance imaging Cerebral blood flow-Cortical steady potential-Focal isch emia-Metabolic imaging-Nonselective cation channels, Hansen, 1993) , and the induction of suicidal genomic responses (Charriaut-Marlangue et aI" 1996; Du et aI" 1996) . Although each of these pathologies involves a cascade of complex and highly specific molecular mechanisms, it is widely accepted that an early abnor mality in the sequel of events must be the activation or inactivation of receptors and ion channels at the plasma membrane. Therapeutic approaches for ameliorating ischemic injury have therefore focused mainly on modu lation of receptor sensitivities and ion conductances.
Among the mechanisms involved, increased calcium fluxes across voltage or receptor-operated calcium chan nels have received particular attention. A peculiar mode of Ca 2 + influx is mediated by capacitative gating of un selective cation channels (Berridge, 1987; Putney, 1990; Fasolato et ai., 1994; Friel, 1996; Zhu et aI" 1996) . These channels are referred to as store-operated cation channels (SaCs) (Wes et aI" 1995) because Ca 2 + influx is acti vated by still unknown signals generated from the deple tion of inositol 1,4,5-triphosphate (IP 3)-sensitive cal-cium stores (Zitt et aI., 1996) . SOCs form a large het erogeneous family whose structures (Wes et aI., 1995; Zhu et aI., 1996; Zitt et aI., 1996) and regulations (Zitt et aI., 1996) are only partly known. The Ca 2 + influx through SOCs leads to an amplification of IP3-activated increase of intracellular [Ca 2 +] and therefore may modulate this response in a cell-specific way. Members of the SOC family play a prominent role in the activation of neutro philic leukocytes during inflammatory events (Von Tscharner et aI., 1986) , and they may be involved in cell degradation and necrosis (Choi, 1988) .
According to Simpson et al. (1995) , neuronal Ca 2 + stores play a crucial role in a variety of physiological and pathophysiological processes. However, the relative im portance of SOC in this process is still poorly understood because of lack of specific pharmacological channel blockers.
Another class of nonselective cation channels is operated by ligands that bind to receptors located at the N-terminal domain of the cation-permeable pore (Ben ham and Tsien, 1987; Inoue and Nakazawa, 1992) . These receptor-activated cation channels allow very fast in creases in cytosolic Na+ and Ca 2 + concentration and thus may contribute to the known disturbances of ion and water homeostasis associated with cerebral isch emia.
The isoquinoline derivative (RS)-(3 ,4-dihydro-6, 7dimethoxyisoquinoline-I-), I )-2-phenyl-N,N-di-[2(2,3,4trimethyoxyphenyl)ethyl]acetamide (LOE 908 MS) is a potent inhibitor of receptor or store-operated channels especially in primary cultures of cortical and hippocam pal neurons (D. Arndts, Boehringer Ingelheim KG, per sonal communication). The agent does not influence the IP3-regulated Ca 2 + release from internal pools but blocks the reactive Ca 2 + entry through SOCs (lCso: 0. 6 /-LM). In HL-60 cells full blockade of ATP-or N-formyl-L methiony 1-L-leucy 1-L-pheny lalanine-stimulated cation currents is achieved at 3 /-LM and half-maximal inhibition at concentrations of as low as 40 nM (Krautwurst et aI., 1993) .
This remarkable pharmacological potency led us to investigate the effects of LOE 908 MS on ischemic in jury induced by permanent middle cerebral artery (MCA) occlusion of rat. By combining advanced mag netic resonance imaging methods with autoradiographic, bioluminescence, and fluorescence imaging techniques, information could be obtained not only on the effect of the drug on infarct volume and on the temporal evolution of the pathological process, but also on the threshold re lationship between reduced blood flow and the result ing metabolic disturbances. Our findings demonstrate that inhibition of SOCs conveys marked protection of the ischemic tissue by alleviating secondary aggravation of the primary ischemic impact.
MATERIAL AND METHODS

General preparations
Eighteen male Wistar rats (350-400 g body wt) were anes thetized with 1.5% halothane in a mixture of 70% N 2 0/30% 0 2 ' Rectal temperature was monitored throughout the experi ment and kept close to 37°C using a feedback-controlled heat ing pad. Animals were tracheotomized, immobilized with pan curonium bromide (0.3 mg/kg/h), and mechanically ventilated. After beginning of artificial ventilation, halothane concentra tion was reduced to 0.8%. Arterial and venous catheters were inserted into the femoral vessels for injection of drugs, moni toring of systemic blood pressure, and blood sampling. Blood gases were measured repeatedly and kept within physiological limits by appropriate settings of the respirator.
For electrophysiological monitoring, the skull over the pari etal cortex was thinned, and a small calomel electrode was attached to the bone using a saline-soaked cotton wick. The indifferent electrode was placed over the nasal bone, and re cordings of EEG and cortical DC potentials were carried out using AC-and DC-coupled differential amplifiers.
Permanent focal ischemia was produced by suture occlusion of the right MCA using a previously described remotely con trolled occluding device (Kohno et aI., 1995) . Briefly a mono filament nylon thread (3-0 Prolene; Ethicon Co., Norderstedt, Germany) with its distal end thickened to 0.28 mm in diameter was connected to an extension catheter and passed through a guide sheath fixed to the neck of the animal. The filament was introduced into the right internal carotid artery via the proximal end of the isolated external carotid artery until the tip reached the carotid canal at the base of the skull. After positioning the animal in the magnet of the magnetic resonance scanner (see later), the MCA was occluded by advancing the filament until EEG amplitude declined and then leaving it in this position throughout the experiment. Artificial punctures of the vessel were excluded by rejecting all animals that exhibited signs of subarachnoidal hemorrhage at the end of the experiments.
Six hours after MCA occlusion, animals were removed from the magnet and measurements of regional blood flow and brain metabolites were performed, as described herein.
Therapeutic interventions
Two groups of animals were compared. The treated group (n = 7) received subcutaneous injections of 30 mg/kg LOE 908 MS (the methane sulfonate salt, courtesy of Boehringer Ingelheim KG, Germany) dissolved in 1 ml saline at 10 min and 3 h after MCA occlusion. The untreated control group (n = 11) was injected subcutaneously with 1 ml saline at the same time points after vascular occlusion.
Magnetic resonance imaging
Magnetic resonance measurements were performed at 200 MHz using a Bruker Biospec system (Bruker Medizintechnik, Karlsruhe, Germany) with a 4.7 T magnet of 30-cm clear bore. The system was equipped with actively shielded gradient coils (Bruker Medizintechnik, Karlsruhe, Germany) with a maxi mum gradient strength of 100 mT/m at a gradient rise time of <250 fLS. A l2-cm-diameter Helmholtz coil was used for ra diofrequency transmission and a l6-mm-diameter surface coil with inductive coupling was placed over the skull for signal reception. The two coils were positioned orthogonally to each other to minimize coupling, and the transmitter coil used active tuning via a pin diode switch to further reduce coupling, while passive decoupling by crossed diodes was used on the surface coil. The active EEG electrode was fed through the center of the surface coil to attach it to the skull. Sagittal and coronal scout scans using TI-weighted spin echo magnetic resonance imaging (echol time = 8 ms, repeti tion time = 600 ms) were performed for correct positioning of the head. Diffusion-weighted magnetic resonance imaging (DWI) was carried out using a multi slice Stejskal-Tanner-type spin echo sequence (Stejskal and Tanner, 1965) . The sequence parameters were echo time = 32 ms, repetition time = 1170 ms, with the diffusion-encoding gradient applied along the ver tical y-gradient axis. The scan time (number of excitations = 2) was 5 min for a 128 2 image matrix. Six coronal slices were measured with an inters lice gap of 0.75 mm, a slice thickness of I mm, and a 40-mm field of view.
For quantitative determination of apparent diffusion coeffi cient (ADC), DWIs with different gradient strengths (b factor: 0, 750, 1,500 s/mm 2 ) were recorded before and after MCA occlusion. During the first 2 h of ischemia, eight two-point ADC measurements (b = 0, 1,500 s/mm 2 ) with lO-min tem poral resolution were recorded. Then, till the end of the experi ment, three-point ADC measurements (b = 0, 750, 1,500 s/mm 2 ) were repeated every 30 min.
To minimize instrumental errors in the ADC determination, extensive data postprocessing including correction for image specific background noise and gradient cross-talk was per formed, as described in detail elsewhere (Eis and Hoehn Berlage, 1995) . ADC was calculated using the monoexponen tial intravoxel incoherent motion model of LeBihan et a!. (1988) .
Measurement of CBF
At the end of the experiment, 6 h after MCA occlusion, local CBF (JCBF) "'fls measured by quantitative autoradiography, using C4C]iodoantipyrine (40 J.LCi/ml; Amersham, Braunsch weig, Germany) as the freely diffusible tracer (Sakurada et a!., 1978). The tracer was infused intravenously over 60 s, and arterial blood samples were collected repeatedly on preweighed filter paper. At the end of tracer infusion, the rats were frozen in situ with liquid nitrogen.
Radioactivity of 20-J.Lm cryostat sections was measured by quantitative autoradiography, using 14C standards and a CCD camera connected to an image-processing system. 14C radio activity of blood was measured in a liquid scintillation counter (Wallac 1410; Pharmacia, Freiburg, Germany), and lCBF was calculated according to the algorithm of Sakurada et a!. (1978) .
Biochemical and histological imaging
Cryostat brain sections adjacent to those used for autoradi ography were collected for imaging of regional tissue pH and of the local distribution of A TP and glucose, using fluorescence and bioluminescence imaging techniques, respectively (Kogure and Alonso, 1978; Paschen et a!., 1981; Csiba et a!., 1983) . Images of tissue pH were calibrated with graded pH standards, and local metabolite content was quantified by correlating the optical density of bioluminescence images with metabolite val ues, measured in small tissue samples by conventional enzy matic techniques. Morphological injury was visualized by his tological staining of cryostat sections with hematoxylin-eosin and cresyl violet. At the time of death, 6 h after vascular oc clusion, the morphologically damaged tissue could be clearly differentiated by its paleness from the normally stained nonin jured brain tissue.
Image analysis
Magnetic resonance images and regional maps of CBF, ATP, glucose and tissue pH were analyzed using a Macintosh com puter (Apple, Cupertino, CA, U.S.A.) and the image-processing software IMAGE (National Institutes of Health, Bethesda, MD, 1997 U.S.A.). Volumes of magnetic resonance or biochemical changes were calculated by summing threshold-defined lesion areas of six coronal slices and expressed as percent of ipsilat eral hemispheric volume. The threshold for ADC changes was set at 80% of control, for ATP loss at 30% of control, and for acidosis at pH 6.3. CBF thresholds of ADC and metabolite changes were determined by matching the calculated lesion volumes with the corresponding values of the flow/volume re lationship.
Statistics
Values are given as means ± SD unless stated otherwise. Statistical differences between groups were evaluated by analy sis of variance, followed by Student's paired t test. Time related changes were assessed by Scheffe's F test. The level of significance was set at p < 0.05.
RESULTS
General physiological observations
Under control conditions all general physiological variables including body temperature were in the normal range ( Table 1) . Occlusion of the MCA led to transient increase of body temperature by -1°C for a few hours. The other variables did not change. In particular, blood pressure remained stable and did not differ between treated and untreated animals.
Electrophysiological observations
Suture occlusion of the MCA caused an instantaneous reduction of the EEG amplitude by >50% in all animals, followed by the return to or close to normal in 5-10 min (Fig. I) . The cortical DC potential consistently exhibited a negative/positive deflection after a latency of 5-6 min lasting for -4 min. This deflection was frequently pre ceded by a brief positive shift of low amplitude. Follow ing this initial DC deflection, subsequent DC shifts oc curred at irregular intervals. The frequency of these shifts differed greatly between treated and untreated animals: In the untreated group, the total number of DC shifts was 6.5 ± 5.3 during the observation period of 6 h, whereas in the LOE 908 MS-treated group, this number was sig nificantly reduced to 2.5 ± 2.3/6 h (p < 0.05). During each DC shift the EEG amplitude transiently declined but not to the same degree as immediately after MCA occlusion (Fig. 1) .
Magnetic resonance imaging
During the control phase before MCA occlusion, DWI did not reveal interhemispheric asymmetries or group differences (Figs. 2 and 3) . The ADC of water was 509 ± 31 and 635 ± 41 f,Lm 2 /s in the lateral and parietal cortex and 590 ± 25 f,Lm 2 /s in the basal ganglia, respectively.
MCA occlusion led to an increase in DWI signal in tensity in the ipsilateral caudate-putamen and part of the temporoparietal cortex. This hyperintensity was visible already in the first postocclusion image recorded be tween 0 and 10 min after onset of ischemia (Fig. 2) . In the untreated group both, intensity and size of the DWI- visible lesion gradually increased during the observation period of 6 h. In contrast, the lesion size remained stable in all LOE 908 MS-treated animals (Fig. 3) .
For quantitative analysis of the volume changes, the ADC lesion volume (defined as the decline of ADC to <80% of control) was measured repeatedly after MCA occlusion and normalized to the initial ischemic impact, recorded at 1 6 min after the onset of ischemia (Fig. 4) . In the untreated animals, the ADC lesion volume briefly declined by -20% and then gradually expanded until, after 6 h, it exceeded the initial volume by -50%. In the treated animals, the lesion volume transiently declined by even 35% and then stabilized at a level that was -20% below the initial value. The difference between treated and untreated groups became significant already 10 min after the injection of LOE 908 MS, and after 6 h the normalized lesion volume of the treated group was 46% smaller. In absolute values, the ADC lesion volume after 6 h of untreated and treated animals amounted to 44 ± 15% and 16 ± 18% of the ipsilateral hemisphere, repre senting a lesion reduction by 64%_ The severity of ADC changes was measured in the center of the ischemic territory. In the untreated animals, ADC declined to 71 % of control within 30 min of vas cular occlusion, followed by further decline to -66% after 1 h and to 50% at the end of the 6-h observation period. In the treated animals, the corresponding values were 78% after 30 min, 75% after 1 h, and 60% after 6 h. These changes are significantly less severe than in the untreated animals, demonstrating that LOE 908 MS re duces not only the volume but also the severity of the ADC-visible lesion.
Blood flow measurements
At the end of each experiment, 6 h after MCA occlu sion, regional CBF was measured by e 4 C]iodoantipyrine autoradiography. In both groups flow values gradually declined from the periphery to the center of the ischemic territory, but the severity of the flow disturbance was distinctly less pronounced in the LOE 908 MS-treated group. This was demonstrated by measuring the volume of reduced blood flow as a function of stepwise declining flow thresholds_ As shown in Fig. 5 , the ischemic terri tory was significantly smaller in the treated animals ir respective of the chosen flow threshold. LOE 908 MS treatment thus significantly improved collateral blood flow to the ischemic territory.
Biochemical and morphological injury
The regions of metabolic and morphological lllJury were identified at the end of the 6-h observation period by imaging the histological lesion and the local distur bances of ATP, glucose, and pH. In the center of the MCA territory, ATP and glucose were consistently de pleted and pH was severely acidic. Visual inspection revealed a marked reduction by LOE 908 MS treatment of the lesion size for all these variables (Fig. 6) .
The degree of protection was quantified by planimet ric evaluation of cresyl violet-stained sections and of A TP and pH images at six coronal levels corresponding to the planes of ADC imaging (Fig. 7) . The volume of A TP depletion was 32.8 ± 17.1 % of the ipsilateral hemi sphere in the untreated animals as compared with 12.9 ± 12.1 % in the treated ones. This corresponds to a reduc tion of the lesion volume by 61 %.
The volume of tissue acidosis, defined as the decline of tissue pH to below 6.3, was 39.7 ± 21.4% of the ipsilateral hemisphere in the untreated group as com pared with 33.7 ± 26.4% in the treated group, corre sponding to a nonsignificant lesion reduction by only 15 %. The volume of morphological injury was similar to that of ATP loss and amounted to 33.0 ± 14.5% of the ipsilateral hemisphere in the untreated group and to 9. 6 ± 6.3% in the treated group. This difference corresponds to a reduction of lesion volume by 71 %.
A TP depletion is a measure of infarct core, whereas tissue acidosis additionally detects the penumbra. There fore, the larger difference of the ATP-visible lesion vol umes demonstrates that LOE 908 MS mainly reduces the size of the infarct core but has little effect on the volume of the penumbra. The flow thresholds for the magnetic resonance visible changes and the metabolic disturbance were es timated by matching the lesion volumes detected by magnetic resonance or biochemical imaging with the corresponding values of the flow/volume relationship shown in Fig. 5 . According to these measurements, the flow thresholds for the decline of ADC, A TP depletion, and morphological injury were lower in the treated group, but that of acidosis markedly increased (Table 2 ). This finding demonstrates that LOE 908 MS diminishes the volume of the ischemic core but not that of the pen umbra of the evolving infarct.
DISCUSSION
Despite considerable progress in the therapy of experi mental ischemia, the results of clinical stroke treatment are still unsatisfactory (del Zoppo, 1995; Grotta, 1995) . Some of the experimentally most potent drugs, notably the various kinds of glutamate antagonists, are not suited for clinical treatment because of unacceptable side ef fects (Auer, 1994; Xue et aI., 1994) . Others, like spin traps (Folbergrova et aI., 1995) or antiinflammatory drugs (del Zoppo, 1994; Feuerstein et aI., 1994) , are of benefit particularly after transient focal ischemia with no or only moderate improvement of ischemic injury after permanent vascular occlusion (Muller et a!., 1995) . Therefore, alternative approaches to prevent brain in farcts are urgently required.
The present study demonstrates that the blocker of store-operated nonselective cation channels, LOE 908 MS, has promising potentials for the treatment of stroke. Both the dose and the application time chosen for the present study are compatible with clinical treatment, and the main finding was a marked retardation of infarct expansion during the initial 6 h of vascular occlusion, which led to the reduction of the volume of A TP depleted tissue by 61% and that of the histologically visible tissue necrosis by 71 % as compared with un treated animals. Temperature changes, in contrast, are probably not of importance because body temperature was carefully controlled and because animals were not craniotomized to preserve thermal stabilization of the ischemic territory by the normothermic ally perfused sur rounding tissues.
The improvement of blood flow is not the result of general cardiovascular alterations, as shown by the ab sence of any changes of systemic physiological vari ables. A possible explanation could be the prevention of leukocyte adhesion at the capillary wall because nonse lective cation channels play a prominent role in cell ac- tivation (Ber r idge, 1987; Irvine et aI., 1988) . Another flow-promoting mechanism could be the reduction of ischemic cell swelling and hence of microcirculatory compression because the activation of nonselective cat ion channels contributes to the increase of intracellular osmolality by gating sodium influx (Krautwurst et a!., 1993) . A protective effect on ischemic fluid shifts has, in fact, been documented in the present study by demon strating a significant reduction of the ADC-visible lesion volume. The other major protective mechanism of LOE 908 MS seems to be the preservation of energy metabolites under conditions of critically reduced blood flow. In pre vious studies from our laboratory (Mies et a!., 1991; Kohno et aI., 1995) , evidence has been provided that the CBP threshold for ATP depletion steadily increases from 13 ml 100 g-l min-1 after 30-min ischemia to 19 ml 100 g-1 min-1 after 1 h and to 23 ml 100 g-1 min-1 after 6 h. The present CBP threshold of 20 ml 100 g-I min-I for the untreated group at 6 h of MCA occlusion comes close to the expected value after this duration of ischemia. CBP threshold for the treated group, in contrast, re mained stable at 15 ml 100 g-1 min-I , which corresponds with the prevention of infarct core expansion.
The retardation of the threshold progression to higher CBP values with time may be due to an inhibition of periinfarct depolarizations, the number of which signifi cantly declined in the treated animals. There is now ample evidence that the generation of periinfarct depo larizations contributes to infarct growth presumably be- Vol. 17. No.5, 1997 cause the constrained collateral blood supply does not couple to the increased energy demands required for re storing the disturbed ion homeostasis (for review see Hossmann, 1996) . The present study is in line with this concept. In fact, reduction of periinfarct depolarization by LOE 908 MS prevented both the gradual increase of the CBF threshold for ATP depletion and the expansion of the magnetic resonance-visible lesion size, which pre viously has been associated with the generation of peri infarct depolarizations (Iijima et aI., 1992; Gyngell et aI., 1995; Busch et aI., 1996) .
Another mechanism for the depolarization-induced in jury in untreated animals could be progressive uncou pling of oxidative phosphorylation (Katsura et aI., 1994; Abe et aI., 1995) . The massive influx of calcium during each depolarization in combination with the hypoxic re tardation of calcium countertransport across the plasma membrane could lead to progressive mitochondrial cal cium loading and a reduction of the mitochondrial oxi dative capacity (Nicholls, 1985) . Suppression of periin farct depolarizations by LOE 908 MS may alleviate this pathophysiology and provides another explanation for the stabilization of the CBP threshold for ATP depletion and the prevention of infarct expansion.
An interesting side aspect of our study was the obser vation that the ADC lesion that was visible immediately FIG. 6. Comparison of apparent diffusion coefficient (ADC) maps with pictorial measurements of blood flow, ATP, glucose, and tissue pH in untreated and LOE 908 MS-treated rats submitted to 6-h middle cerebral artery occlusion. Quantitative ADC maps were calculated from three diffusion-weighted images with in· creasing b factors. Biochemical measurements were color-coded for highlighting pathological changes. Images were taken from three levels, passing through the frontal, central, and posterior parts of brain infarcts, respectively. Note smaller and less severe biochemical and magnetic resonance-visible lesions in the treated animal. after vascular occlusion became smaller in size a few minutes later. This volume reduction was modest and transient in the untreated animals but more pronounced and long-lasting in the treated ones. The most likely rea son for the partial reversal of the initial ADC lesion is the activation of the collateral circulation, which takes some time to establish (Shima et aI., 1983 ) and seems to be more efficient in the treated animals. However, it cannot be excluded that the initial ADC lesion volume is modu lated by the early depolarization that occurs shortly after MCA occlusion (Iijima et aI., 1992) , in agreement with the findings in -50% of the investigated animals. The first ADC image of the evolving ischemic infarct may therefore exaggerate the actual lesion size and should be interpreted with caution, particularly in regard to thera peutic interventions. Obviously, retardation of infarct core expansion as shown in this study is not equivalent with the reversal of the ischemic impact, at least not during the observation period of 6 h. The main therapeutic interest of LOE 908 MS is therefore the extension of the therapeutic window for subsequent flow-promoting interventions. This could be of considerable importance for improving the thera peutic outcome of thrombolysis, which is still unsatis factory even when therapy is started within a few hours after stroke onset (Hacke et ai., 1995; Marler et ai., 1995) . The decline of the apparent diffusion coefficient (ADC) of brain water was defined as the reduction to less than 80% of control, A TP depletion as the decline to less than 30% of control, acidosis as the decline of tissue pH below 6.3, and morphological injury as the loss of histological staining. Thresholds were calculated by matching the mean lesion volumes shown in Fig. 7 with the corresponding values of the flow/volume relationship shown in Fig. 5 .
The present study does not provide information on the cerebroprotective aspect of LOE 908 MS on the chronic infarct situation because experiments were terminated at 6 h after vascular occlusion. However, during this time LOE 908 MS markedly retards the manifestation of ir reversible tissue injury and thus provides a rather long therapeutic window for the restoration of blood recircu lation by thrombolysis. This would give ample time to evaluate the risks of bleeding and to allow careful selec tion of patients that can be expected to benefit from this therapy. Experiments are underway to explore this chal lenging prospect.
